Facebook
Twitter
LinkedIn
ForwardThis is a working tumor board that covers active cases of patients with bone and soft tissue lesions associated with sarcoma (connective tissue neoplasms), metastatic carcinoma, and some metabolic bone disease. We discuss treatment plans/options/protocols for newly diagnosed and/or established adult musculoskeletal oncology patients based on the most up to date data/literature, evidence- based medicine, outcomes of our own research, and data accumulated at our tumor board via our ongoing data base.
Sarcoma, Connective Tissue Neoplasms, Metastatic Carcinoma, Metabolic Bone Diseases
- Physicians
- Nurse Practitioners
- Physician Assistants
- Nurses
- students, residents, research coordinators, fellows
Participants who engage in this educational intervention will be able to:
- Discuss treatment outcomes in comparison to the standard of care in evidence-based medicine and literature.
- Collaborate research efforts and establish research studies based on our findings and publish our outcomes.
- Continue to strengthen the multidisciplinary relationships that have evolved over the many years since this tumor board was established.
- Apply recent updates to treatment plans and protocols based on the discussions of the patient’s treatment at tumor board
- Expand our discussions to include the most recent and relevant literature evaluations on musculoskeletal oncology and disease protocols and treatment outcomes
- Continue to collaborate as a multidisciplinary unit to treat the patient as a whole and utilize treatment resources efficiently
- Publish research that is up to date and relevant to current literature
- Keith Baynes, MD Associate Professor Section Chief Musculoskeletal Imaging
- Manpreet Bedi, MD Professor, Radiation Oncology, Sarcoma Program Director
- Callisia Clarke, MD, MS, FACS, FSSO Associate Professor Surgical Oncology
- Melissa DuBois, MD Associate Professor Radiology
- Lori Hollingsworth-Burds, PA-C, MPAS Orthopaedic Surgery, Oncology
- Keenan Horness, PA-C, MPAS Orthopaedic Surgery, Oncology
- Alexandra Istl, MD, MPH, FRCSC, Assistant Professor Surgical Oncology
- Brandon Key, MD Assistant Professor VIR Radiology
- David King, MD Chair Professor Orthopaedic Surgery, Oncology
- Krisztian Kovacs, MD, Assistant Professor Pathology
- John LoGiudice, MD Professor Plastic Surgery
- Rajeev Mannem, MD Chief Associate Professor Radiology
- Jennifer Merrill, APNP Surgical Oncology
- John Neilson, MD Associate Professor Orthopaedic Surgery, Oncology
- Brandon Rebholz, MD Associate Professor Orthopaedic Surgery, Spine
- Nathan Schloemer, MD Assistant Professor Hematology and Oncology, Pediatric
- Sean Veenendaal, PA-C, MPAS Orthopaedic Surgery, Oncology
- Matt Vickery, MD Assistant Professor Radiology
- Adam Wooldridge, MD, MPH Assistant Professor Orthopaedic Surgery, Oncology
The following persons in control of content disclosed the following financial relationships which were reviewed via the MCW conflict of interest mitigation process and addressed.
| Name | Company | Role |
|---|---|---|
| Hackbarth, Donald, MD, FACS, FAAOS | MTF Biologics | Board Member |
Charlson, John, MD | Decipher Adaptimmune | Advisory Committee Advisory Committee |
Contact
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 1.00 hours of participation for continuing education for allied health professionals.